Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.444
+0.006 (1.32%)
At close: Apr 28, 2026, 4:00 PM EDT
0.434
-0.010 (-2.23%)
After-hours: Apr 28, 2026, 7:41 PM EDT
Silo Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Revenue Growth (YoY) | - | - | - | 1.18% | - | |
| Cost of Revenue | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Gross Profit | 0.03 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Selling, General & Admin | 2.15 | 2.4 | 3.08 | 2.43 | 2.27 | |
| Research & Development | 2.16 | 2.37 | 0.85 | 1.29 | 0.69 | |
| Operating Expenses | 4.31 | 4.77 | 3.92 | 3.71 | 2.96 | |
| Operating Income | -4.28 | -4.71 | -3.86 | -3.65 | -2.89 | |
| Interest Expense | -0.04 | -0.01 | -0 | -0 | -0 | |
| Interest & Investment Income | 0.19 | 0.33 | 0.4 | 0.07 | 0 | |
| Currency Exchange Gain (Loss) | - | -0.01 | - | - | - | |
| Other Non Operating Income (Expenses) | -0.1 | - | - | - | - | |
| EBT Excluding Unusual Items | -4.23 | -4.39 | -3.46 | -3.58 | -2.89 | |
| Gain (Loss) on Sale of Investments | 0 | -0 | -0 | -0.44 | 6.91 | |
| Other Unusual Items | - | - | -0.17 | 0.11 | 0.17 | |
| Pretax Income | -4.23 | -4.39 | -3.63 | -3.91 | 4.18 | |
| Income Tax Expense | - | - | - | - | 0.02 | |
| Earnings From Continuing Operations | -4.23 | -4.39 | -3.63 | -3.91 | 4.16 | |
| Earnings From Discontinued Operations | - | - | -0.07 | -0 | -0.25 | |
| Net Income | -4.23 | -4.39 | -3.7 | -3.91 | 3.9 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.4 | |
| Net Income to Common | -4.23 | -4.39 | -3.7 | -3.91 | 2.5 | |
| Shares Outstanding (Basic) | 8 | 4 | 3 | 2 | 2 | |
| Shares Outstanding (Diluted) | 8 | 4 | 3 | 2 | 2 | |
| Shares Change (YoY) | 127.75% | 19.50% | 34.83% | 19.07% | 45.44% | |
| EPS (Basic) | -0.50 | -1.19 | -1.20 | -1.71 | 1.32 | |
| EPS (Diluted) | -0.50 | -1.19 | -1.20 | -1.71 | 1.30 | |
| Gross Margin | 38.57% | 91.90% | 91.90% | 91.90% | 92.98% | |
| Operating Margin | -5936.95% | -6526.44% | -5347.41% | -5059.02% | -4059.33% | |
| Profit Margin | -5863.50% | -6092.59% | -5132.57% | -5420.86% | 3507.72% | |
| EBITDA | -4.27 | -4.7 | - | - | - | |
| D&A For EBITDA | 0.01 | 0.01 | - | - | - | |
| EBIT | -4.28 | -4.71 | -3.86 | -3.65 | -2.89 | |
| Effective Tax Rate | - | - | - | - | 0.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.